Lipids in Health and Disease

Table 2 Correlation coefficients between CACS and clinical variables in two statin benefit groups^a based on statin-intensity class of drug

From: Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals

Total = 2886	Moderate-intensity statin therapy group (n = 1602)		High-intensity statin therapy group (n = 1284)
	Correlation	p-value	Correlation	p-value
Age, year	0.202	<0.001	0.216	<0.001
Body mass index, kg/m²	0.013	0.595	0.012	0.684
Waist circumference, cm	0.026	0.299	0.041	0.151
Systolic BP, mm Hg	0.092	<0.001	0.102	<0.001
Diastolic BP, mm Hg	0.051	0.042	0.012	0.674
Heart rate, beats per minute	0.010	0.704	0.082	0.004
Total cholesterol, mg/dL	0.049	0.053	0.127	<0.001
Triglyceride, mg/dL	0.026	0.310	0.012	0.677
HDL-C, mg/dL	- 0.010	0.699	- 0.006	0.835
LDL-C, mg/dL	0.061	0.016	0.144	<0.001
Fasting blood glucose, mg/dL	0.091	<0.001	0.109	<0.001
HbA1c, %	0.097	<0.001	0.179	<0.001
Fasting insulin, IU/L	0.006	<0.001	0.012	0.709
HOMA-IR,	0.033	0.224	0.034	0.281
C reactive protein, mg/dL	0.028	0.281	0.012	0.685
Ten-year ASCVDS, %	0.112	<0.001	0.254	<0.001

^aStatin benefit group was defined as individuals who should be considered moderate- and high-intensity statin therapy
CAC coronary artery calcium, BP blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment insulin resistance, ASCVD atherosclerotic cardiovascular disease

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com